Approfondimenti sulla terapia domiciliare del COVID‑19/feed/ISRCTN10697380

Search Results

Global prevalence and gastrointestinal symptom burden of individuals with a history of cholecystectomy

Background Cholecystectomy is commonly performed globally, and many patients with disorders of gut-brain interaction (DGBI) report that their symptoms have either preceded or developed following cholecystectomy. Objective To determine the global prevalence of a self-reported history of a cholecyste…
Read More Read More: Global prevalence and gastrointestinal symptom burden of individuals with a history of cholecystectomy Data di pubblicazione: Dicembre 2025

NCCN: linee guida sul cancro al seno

Cancro al seno

Cancro al seno

Il panorama del trattamento del cancro al seno invasivo in stadio precoce e metastatico è in costante evoluzione. Nella versione 2025...
Read More Read More: NCCN: linee guida sul cancro al seno

Adesione ai trattamenti ASA + Statine in medicina generale: evidenze da uno studio italiano real-world

Notizie dalla Ricerca

Notizie dalla Ricerca

Questo studio real-world basato mostra un punto molto chiaro: i pazienti che assumono ASA e statina come due farmaci separati hanno livelli...
Read More Read More: Adesione ai trattamenti ASA + Statine in medicina generale: evidenze da uno studio italiano real-world

[Articles] Effect of subcutaneous lidocaine–hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study

Subcutaneous lidocaine–HP-β-CD was associated with significantly improved quality of life and symptom burden in patients with post–COVID. This home-administered intervention offers a scalable and potentially disease-modifying approach for a disabling condition with no approved treatment to date.
Read More Read More: [Articles] Effect of subcutaneous lidocaine–hydroxypropyl-β-cyclodextrin (HP-β-CD) on quality of life in patients with post-COVID condition: a 36-week observational interrupted time series study Data di pubblicazione: Dicembre 2025

Life Expectancy After the COVID-19 Pandemic

To the Editor Dr Schwandt and colleagues’ recent study contributes to understanding racial disparities in life expectancy during and after the COVID-19 pandemic. Their analysis highlights how Black and Hispanic populations experienced the greatest declines, and recovery remains incomplete. However,…
Read More Read More: Life Expectancy After the COVID-19 Pandemic Data di pubblicazione: Dicembre 2025

First-Trimester COVID-19 Vaccination Not Associated With Congenital Risks

A nationwide cohort study in France found no differences in major congenital malformations among infants exposed to the messenger RNA (mRNA) COVID-19 vaccine and those who were not exposed to the vaccine during their mothers’ first trimester of pregnancy.
Read More Read More: First-Trimester COVID-19 Vaccination Not Associated With Congenital Risks Data di pubblicazione: Dicembre 2025

Life Expectancy After the COVID-19 Pandemic—Reply

In Reply We thank Ms Wilson and colleagues for commenting on our Research Letter. We share their concerns about the scarcity of epidemiological data on the American Indian and Alaska Native population. The scarcity has many causes, including a long history of disinterested policymakers, but also te…
Read More Read More: Life Expectancy After the COVID-19 Pandemic—Reply Data di pubblicazione: Dicembre 2025

Long COVID Trial Explores Anti-Inflammatory Treatment

Inflammation is believed to contribute to long COVID. A recent randomized clinical trial investigated whether the anti-inflammatory agent colchicine could be used to treat the condition.
Read More Read More: Long COVID Trial Explores Anti-Inflammatory Treatment Data di pubblicazione: Dicembre 2025

CMAJ: nuove linee guida sulla prevenzione dell’HIV prima e dopo l’esposizione

HIV

HIV

Sono ora disponibili trattamenti pre-esposizione multipla (PrEP) e post-esposizione (PEP) per prevenire l’infezione da HIV....
Read More Read More: CMAJ: nuove linee guida sulla prevenzione dell’HIV prima e dopo l’esposizione

Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants

This study assesses the durability of protection provided by updated COVID-19 vaccines over a 7-month period, during which circulating SARS-CoV-2 variants were predominantly JN.1 descendants.
Read More Read More: Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants Data di pubblicazione: Dicembre 2025

Evidence, Opinion, and Uncertainty About COVID-19 Vaccines

This issue of JAMA Internal Medicine includes a Research Letter by Du and colleagues reporting findings that once again demonstrate that vaccination with a SARS-CoV-2 vaccine booster with an updated vaccine formulation was associated with significant reductions in the risk of serious adverse outcom…
Read More Read More: Evidence, Opinion, and Uncertainty About COVID-19 Vaccines Data di pubblicazione: Dicembre 2025

Effectiveness of Colchicine for the Treatment of Long COVID

This randomized clinical trial evaluates the superiority of colchicine over placebo among adults with long COVID in improving functional outcome at 52 weeks from baseline.
Read More Read More: Effectiveness of Colchicine for the Treatment of Long COVID Data di pubblicazione: Dicembre 2025

Manutenzione Straordinaria dei Servizi Online di AIFA

Si informano gli utenti dei servizi online di AIFA che gli stessi non saranno disponibili dalle ore 16.00 alle ore 19 di martedì 02 dicembre 2025.
Read More Read More: Manutenzione Straordinaria dei Servizi Online di AIFA Data di pubblicazione: Novembre 2025

“Mia madre è stata dimessa dall’ospedale, come faccio ad attivare le cure domiciliari?”

Mia madre ha 82 anni, è stata dimessa dall’ospedale dopo una frattura al femore e non può muoversi. Mi hanno parlato dell’Assistenza Domiciliare Integrata, ma non so da dove cominciare….
Read More Read More: “Mia madre è stata dimessa dall’ospedale, come faccio ad attivare le cure domiciliari?” Data di pubblicazione: Novembre 2025

What Is Cardiac Long COVID?

This Medical News article is an interview with the lead author of a new European Society of Cardiology clinical consensus statement on cardiovascular disease prevention and management in COVID-19.
Read More Read More: What Is Cardiac Long COVID? Data di pubblicazione: Novembre 2025
Close Search Window
Close